50.2 F
Laguna Hills
Tuesday, Feb 18, 2025
-Advertisement-

Boston Scientific Completes $3.7B Acquisition of Axonics

Co-Founder and CEO Raymond Cohen to Exit

Boston Scientific Corp. (NYSE: BSX) announced that it has closed on its acquisition of Irvine-based medical device maker Axonics Inc. (Nasdaq: AXNX) for $3.7 billion.

The acquisition, first announced in January, will help Boston Scientific expand into the sacral neuromodulation market, according to Megan Scanlon, senior vice president and president at Boston Scientific.

Co-founder and Chief Executive Raymond Cohen in September told the Business Journal that he’d exit the company once the sale closes.

Shares in Axonics were relatively unchanged at $70.98 and a $3.6 billion market cap on Nov. 15 the day the news was announced.

See the Business Journal’s Nov. 25 issue for more information.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Yuika Yoshida
Yuika Yoshida
Yuika Yoshida has been a reporter covering healthcare, innovation and education at the Orange County Business Journal since 2023. Previous bylines include JapanUp! Magazine and Stu News Laguna. She received her bachelor's degree in literary journalism from the University of California, Irvine. During her time at UC Irvine, she was the campus news editor for the official school paper and student writer for the Samueli School of Engineering. Outside of writing, she enjoys musical theater and finding new food spots within Orange County.
-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-